--FILE--View of the China headquarters of AstraZeneca in Pudong, Shanghai, China, 23 July 2013. AstraZeneca Plc is increasing its investment in Chin
RMID:Image ID:W92JGH
Image details
Contributor:
Imaginechina Limited / Alamy Stock PhotoImage ID:
W92JGHFile size:
28.8 MB (940.1 KB Compressed download)Releases:
Model - no | Property - noDo I need a release?Dimensions:
3888 x 2592 px | 32.9 x 21.9 cm | 13 x 8.6 inches | 300dpiDate taken:
23 July 2013Photographer:
ImaginechinaMore information:
--FILE--View of the China headquarters of AstraZeneca in Pudong, Shanghai, China, 23 July 2013. AstraZeneca Plc is increasing its investment in China, where sales rose 21 percent in the second quarter, as the country continues its crackdown on malfeasance in the health-care industry. The UKs second-biggest drugmaker has added more sales people in China as the countrys medical coverage expands, even as prices have declined.